Analgesic Antipyretic Injection
Composition:Each 1 ml. contains:
Dipyrone 500 mg.
Dipyrone, like other non-steroidal anti-inflammatory drugs, acts by inhibiting cyclo-oxygenase mediated production of prostaglandins.
It has analgesic, antipyretic and slight anti-inflammatory properties and reportedly has antispasmodic activity on bradykinin-induced spasms on the intestinal tract, but does not appreciably alter spontaneous intestinal motility.
Dipyrone, the active ingredient of Pyrogesic, is a derivative of the pyrazolon Analgesics. It is an effective analgesic, anti-inflammatory and antipyretic drug. These effects are due to its analgesic action over the Central Nervous system, leading to pain relief and quietening of the animal.
Pyrogesic proved to be effective against wide range of symptoms of colic, spasmodic conditions, hypermotility of intestine, paresis, both acute and chronic rheumatic conditions (Rheumatism, Neuritis Tendo-vaginitis), pain, fever, Mastitis.
Doses and Administration:
- By subcutaneous, intramuscular or intravenous (slow) injection.
- Horses: 11-22 mg/kg body weight.
- (Equivalent to 2.2-4.4 ml/100 kg b. wt.)
- Dogs and Cats: 27.5 mg/kg body weight.
- (Equivalent to 0.55 ml/10 kg b. wt.)
Contra-indications and Precautions:
- Dipyrone is physically incompatible with apmorphine, aspirine, chloral hydrate and oxidizing agents.
- Contraindicated in animals with history of hematological or bone marrow abnormalities.
- Dipyrone should not be used concurrently with phenylbutazone or barbiturates.
- Concomitant administration with chloropromazine may cause serious hypothermia.
- In horses do not administer the drug within 5 days before racing.
Store in a dark place at a temperature below 30 C.
20, 50 and 100 ml amber glass bottles
FOR VETERINARY USE ONLY